How are we doing? Give us your feedback on the new rheumatology.org.

Share Feedbackexternal link opens in a new tab.
Email

Juvenile Idiopathic Arthritis Guideline

Logo

Guideline Status

Step 10: Final guideline published and disseminated


See a list of all clinical practice guideline project steps on the Clinical Practice Guidelines page. 

2021 JIA Oligoarthritis, TMJ, and sJIA Guideline

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Documents related to the 2021 JIA oligoarthritis, TMJ, and sJIA guideline:

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 1 – Methods

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 2 – Search Strategies

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 3 – Evidence Report

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 4 – List of Outcomes

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 5 – Panels/Teams Involved

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 6 – Study Selection

JIA Oligoarthritis, TMJ, and sJIA Guideline Supplementary Appendix 7 – Research Agenda

JIA Oligoarthritis, TMJ, and sJIA Guideline Project Plan

JIA Oligoarthritis, TMJ, and sJIA Guideline Public Comments

JIA Oligoarthritis, TMJ, and sJIA Guideline Author Response to Public Comments

2021 JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Documents related to the 2021 JIA nonpharmacologic, medication monitoring, immunizations, and imaging guideline:

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 1 – Methods

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 2 – Search Strategies

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 3 – Evidence Report

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 4 – List of Outcomes

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 5 – Panel Teams

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 6 – Study Selection

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging Guideline Supplementary Appendix 7 – Research Agenda

2019 JIA Guideline

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis

Documents related to the 2019 JIA guideline:

JIA Guideline Supplementary Appendix 1 – Methods

JIA Guideline Supplementary Appendix 2 – Panel Teams

JIA Guideline Supplementary Appendix 3 – Outcomes Framework

JIA Guideline Supplementary Appendix 4 – Search Strategies

JIA Guideline Supplementary Appendix 5 – Study Selection

JIA Guideline Supplementary Appendix 6 – Evidence Report

JIA Guideline Disclosure Summary

JIA Guideline Project Plan

JIA Guideline Public Comments

JIA Guideline Author Response to Public Comments

2019 JIA Uveitis Guideline

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis

Documents related to the 2019 JIA uveitis guideline:

JIA Uveitis Guideline Supplementary Appendix 1 – Methods

JIA Uveitis Guideline Supplementary Appendix 2 – Panel Teams

JIA Uveitis Guideline Supplementary Appendix 3 – Search Strategies

JIA Uveitis Guideline Supplementary Appendix 4 – Study Selection

JIA Uveitis Guideline Supplementary Appendix 5 – Evidence Report

JIA Uveitis Guideline Supplementary Appendix 6 – Dropped PICO Questions

JIA Uveitis Guideline Disclosure Summary

We use cookies on our website to improve our service to you and for security purposes. By continuing to use our site without changing your browser cookie settings, you agree to our cookie policy and the use of cookies. See ACR Policies